Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors

Genes Chromosomes and Cancer

Volumn 24, Issue 1, 1999, Pages 30-41

  Pedeutour, Florence ^a,b   Forus, Anne ^c   Coindre, Jean Michel ^d   Berner, Jeanne Marie ^c   Nicolo, Guido ^e   Michiels, Jean François ^f   Terrier, Philippe ^g   Ranchere Vince, Dominique ^h   Collin, Françoise ⁱ   Myklebost, Ola ^c   Turc Carel, Claude ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Laboratoire d'Anatomie Pathologique   (France)

^e UNIVERSITY OF GENOA   (Italy)

^f PASTEUR HOSPITAL   (France)

^g INSTITUT GUSTAVE ROUSSY   (France)

^h CENTRE LÉON BÉRARD   (France)

ⁱ CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CENTROMERE; CHROMOSOME 12Q; CHROMOSOME SATELLITE; CLINICAL ARTICLE; DNA HYBRIDIZATION; DOUBLE MINUTE CHROMOSOME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOMA; LIPOSARCOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RING CHROMOSOME; SOFT TISSUE TUMOR;

AGED; AGED, 80 AND OVER; BLOTTING, SOUTHERN; CENTROMERE; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 12; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DNA PROBES; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIPOSARCOMA; MALE; MIDDLE AGED; NEOPLASMS, ADIPOSE TISSUE; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RING CHROMOSOMES;

EID: 0032890294     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P     Document Type: Article

References (46)

1. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K. 1995. Disruption of the architectural factor HMGI-C DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65.
2. Berner JM, Meza-Zepeda LA, Kools PFJ, Forus A, Schoenmakers EFPM, Van de Ven WJM, Fodstad O, Myklebost O. 1997. The HMGIC gene is amplified, rearranged and overexpressed in a subset of human sarcomas. Oncogene 17:2935-2945.
3. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
4. Dal Cin P, Kools P, Sciot R, De Wever I, Van Damme B, Van de Ven W, Van der Berghe H. 1993. Cytogenetic and fluorescent in situ hybrization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet 68:85-90.
5. Depinet T, Zackowski JL, Earnshaw WC, Kaffe S, Sekhon GS, Stallard R, Sullivan BA, Vance GH, Van Dyke, Willard HF, Zinn AB, Schwartz S. 1997. Characterization of neo-centromeres in marker chromosomes lacking detectable alpha-satellite DNA. Hum Mol Genet 6:1195-1204.
6. Du Sart D, Cancilla MR, Earle E, Mao JI, Saffery R, Tainton KM, Kalitsis P, Martyn J, Barry AE, Choo A. 1997. A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA. Nat Genet 16:144-153.
7. Enzinger FM, Weiss SW. 1995. Soft Tissue Tumors. St. Louis: C.V. Mosby.
8. Fletcher CDM, Akerman M, Dal Cin P, de Wever I, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van den Berghe H, van de Ven W, Vanni R, Willen H. 1996. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the chromosomes and morphology (CHAMP) collaborative study group. Am J Pathol 148:623-630.
9. Forus A, Flørenes VA, Maelandsmo GM, Meltzer PS, Fodstad Ø, Myklebost O. 1993. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: Some amplica do not include MDM2. Cell Growth Differ 4:1065-1070.
10. Forus A, Olde Weghuis D, Smeets D, Fodstad O, Myklebost O, Geurts van Kessel A. 1995. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14:8-14.
11. Harrington JH, Van Bokkelen GV, Mays RW, Gustashaw K, Willard HF. 1997. Formation of de novo centromeres and construction of first generation human artificial chromosomes. Nat Genet 15:345-355.
12. ISCN. 1995. An international system for human cytogenetic nomenclature. In: Mitelman F, editor. Basel: S. Karger.
13. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, Look AT. 1994. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53:5535-5541.
14. Knuutila S, Nylund SJ, Wessman M, Larramendy ML. 1994. Analysis of genotype and phenotype on the same interphase or mitotic cell. A manual of MAC (morphology antibody chromosomes) methodology. Cancer Genet Cytogenet 72:1-15.
15. Ladanyi M, Lewis R, Jhanwar SC, Gerald W, Huvos AG, Healey JH. 1995. MDM2 and CDK4 amplification in Ewing's sarcoma. J Pathol 175:211-217.
16. Lejeune J. 1968. De la duplication des structures circulaires. Ann Genet 11:71-77.
17. Luna L, Johnsen O, Skartlien AH, Pedeutour F, Turc-Carel C, Prydz H, Kolsto AB. 1994. Molecular cloning of a putative novel human bZip transcription factor on chromosome 17q22. Genomics 22:553-562.
18. McClintock B. 1932. Correlation of ring-shaped chromosomes with variegation in Zea mays. Proc Natl Acad Sci USA 18:677-681.
19. Mitelman F. 1994. Catalog of Chromosome Aberrations in Cancer, 5th Ed. New York: Wiley-Liss.
20. Montgomery KT, LeBlanc JM, Tsai P, McNinch JS, Ward DC, DeJong P, Kucherlapati R, Krauter KS. 1993. Characterization of two chromosome 12 cosmid libraries and development of STSs from cosmids mapped by FISH. Genomics 17:682-693.
21. Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B, Dutrillaux B. 1994. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chromosomes Cancer 10:160-170.
22. Nakayama T, Toguchida J, Wadayama B, Kanoe H, Kotoura Y, Sasaki MS. 1995. MDM2 gene amplification in bone and soft tissue tumors: Association with tumor progression in differentiated adipose-tissue tumors. Int J Cancer 64:342-346.
23. Nilbert M, Rydholm A, Willén H, Mitelman F, Mandahl N. 1994. MDM2 gene amplification correlates with ring chromosomes in soft tissue tumors. Genes Chromosomes Cancer 9:261-265.
24. Nilbert M, Rydholm A, Mitelman F, Meltzer P, Mandahl N. 1995. Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet 83:32-36.
25. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83.
26. Örndal C, Mandahl N, Rydholm A, Willen H, Brosjo O, Heim S, Mitelman F. 1992. Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy. Cancer Genet Cytogenet 66:133-134.
27. Pedeutour F, Suijkerbuijk RF, Forus A, Van Gaal J, Van de Klundert W, Coindre JM, Nicolo G, Collin F, Van Haelst U, Huffermann K, Ture-Carel C. 1994. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer 10: 85-94.
28. Pilotti S, Della Torre G, Lavarino C, Di Palma S, Sozzi G, Minoletti F, Rao S, Pasquini G, Azzarelli A, Rilke F, Pierotti MA. 1997. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: Implications for different pathogenetic mechanisms. J Pathol 181:14-24.
29. Quesnel B, Prudhomme C, Fournier J, Fenaux P, Peyrat JP. 1994. MDM2 gene amplification in human breast cancer. Eur J Cancer 30:982-984.
30. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP. 1993. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736-2739.
31. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. 1994. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54:4299-4303.
32. Schoenmakers F, Wanschura S, Mols R, Bullerdick J, Van den Berghe H, Van de Ven WJM. 1995. Recurrent rearrangement in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 10:436-443.
33. Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, Terrier-Lacombe MJ, Mandahl N, Craver RD, Blin N, Sozzi G, Turc-Carel C (group 1); O'Brien K, Kedra D, Fransson I, Guilband C, Dumanski J (group 2). 1997. Deregulation of the platelet-derived-growth factor B-chain via its fusion with the collagen gene (COL1A1) in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15:95-98.
34. Sreekantaiah C, Leong SPF, Karakousis CP, McGee DF, Rappaport WD, Villar HV, Neal D, Fleming S, Wankel A, Herrington PF, Carmona R, Sandberg AA. 1991. Cytogenetic profile of 109 lipomas. Cancer Res 51:422-433.
35. Stark GR. 1993. Regulation and mechanisms of mammalian gene amplification. Adv Cancer Res 61:87-113.
36. Stephenson CF, Berger CS, Leong SPL, Davis JR, Sandberg AA. 1992. Analysis of a giant marker chromosome in a well-differentiated liposarcoma using cytogenetics and fluorescent in situ hybridization. Cancer Genet Cytogenet 61:134-138.
37. Su YA, Trent JM, Guan X-Y, Meltzer PS. 1995. Direct isolation of genes encoded within a homogeneously staining region by chromosome dissection. Proc Natl Acad Sci USA 91:9121-9125.
38. Suijkerbuijk RF, Olde Weghuis DEM, Van den Berg M, Pedeutour F, Forus A, Myklebost O, Glier C, Turc-Carel C, Geurts van Kessel A. 1994. Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas. Genes Chromosomes Cancer 9:292-295.
39. Szymanska J, Mandahl N, Mertens F, Tarkkanen M, Karaharju E, Knuutila S. 1996a. Ring chromosomes in periosteal osteosarcoma contain sequences from 12q13-15: A combined cytogenetic and comparative genomic hybridization study. Genes Chromosomes Cancer 16:31-34.
40. Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Seljavaara S, Tukiainen F, Elomaa I, Knuutila S. 1996b. Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer 15:89-94.
41. Szymanska J, Virolainen M, Tarkkanen M, Wiklund T, Asko-Seljavaara S, Tukiainen K, Elomaa I, Blomqvist C, Knuutila S. 1997. Overepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: A comparative genomic hybridization study. Cancer Genet Cytogenet 99:14-18.
42. Tallini G, Dal Gin P, Rhoden KJ, Chiapetta G, Manfioletti G, Giancotti V, Fusco A, Van den Berghe H, Sciot R. 1997. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors. Immunohistochemical reactivity correlates with karyotypic alterations. Am J Pathol 151:37-43.
43. Weiss SW, Rao VK. 1992. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up of 92 cases with analysis of the incidence of "dedifferentiation." Am J Surg Pathol 16:1051-1058.
44. Weiss SW, Sobin LH. 1994. Histological Typing of Soft Tissue Tumours. Berlin: Springer Verlag.
45. Wolf M, Aaltonen LA, Szymanska J, Tarkkanen M, Blomqvist C, Berner JM, Myklebost O, Knuutila S. 1997. Complexity of 12q13-22 amplicon in liposarcoma: Microsatellite repeat analysis. Genes Chromosomes Cancer 18:66-70.
46. Wyandt HE. 1988. Ring autosomes: Identification, familial transmission, causes of phenotypic effects and in vitro mosaiscism. In: Daniel A, editor. The cytogenetics of mammalian autosomal rearrangements. New York: AR Liss, p 667-695.